Inhibition of the recruitment of inflammatory cells by the tachykinin NK3 receptor antagonist, SR 142801, in a murine model of asthma

被引：0

作者：

Nenan, S. ^{[1
]}

Germain, N. ^{[1
]}

Lagente, V. ^{[1
]}

Emonds-Alt, X. ^{[2
]}

Advenier, C. ^{[3
]}

Boichot, E. ^{[1
]}

机构：

[1] Univ Rennes 1, Fac Pharm, INSERM, U456, F-35014 Rennes, France

[2] Sanofi Synthelabo Rech, Montpellier, France

[3] Univ Paris 05, Lab Pharmacol, F-75270 Paris 06, France

来源：

FUNDAMENTAL & CLINICAL PHARMACOLOGY | 2001年 / 15卷

关键词：

D O I：

暂无

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：118 / 118

页数：1

共 44 条

[31] Randomized, double-blind study of SR142801 (Osanetant). A novel neurokinin-3 (NK3) receptor antagonist in panic disorder with pre- and posttreatment cholecystokinin tetrapeptide (CCK-4) challenges
Kronenberg, G
Berger, P
Tauber, RF
Bandelow, B
Henkel, V
Heuser, I
PHARMACOPSYCHIATRY, 2005, 38 (01) : 24 - 29
[32] Randomized, double-blind study of SR142801 (Osanetant), a novel neurokinin-3 (NK3) receptor antagonist in panic disorder with pre- and posttreatment cholecystokinin tetrapeptide (CCK-4) challenges
Kronenberg, G
Heuser, I
BIOLOGICAL PSYCHIATRY, 2004, 55 : 123S - 124S
[33] Inhibition of neurogenic oedema formation by a tachykinin NK1 receptor antagonist, SR140333, but not by a bradykinin antagonist, HOE140, in rat skin
Towler, PK
Brain, SD
BRITISH JOURNAL OF PHARMACOLOGY, 1996, 119 : P203 - P203
[34] Histamine 4 receptor activation induces recruitment of FoxP3+ T cells and inhibits allergic asthma in a murine model
Morgan, Ross K.
McAllister, Brian
Cross, Lillian
Green, Daniel S.
Kornfeld, Hardy
Center, David M.
Cruikshank, William W.
JOURNAL OF IMMUNOLOGY, 2007, 178 (12): : 8081 - 8089
[35] IDENTIFICATION OF METHIONINE134 AND ALANINE146 IN THE 2ND TRANSMEMBRANE SEGMENT OF THE HUMAN TACHYKININ NK3 RECEPTOR AS RESIDUES INVOLVED IN SPECIES-SELECTIVE BINDING TO SR-48968
WU, LH
VARTANIAN, MA
OXENDER, DL
CHUNG, FZ
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1994, 198 (03) : 961 - 966
[36] INHIBITORY EFFECTS OF BENCYCLOQUIDIUM BROMIDE, A NOVEL MUSCARINIC M3 RECEPTOR ANTAGONIST, ON AIRWAY HYPERRESPONSIVENESS, INFLAMMATION AND REMODELING IN A MURINE MODEL OF ASTHMA
Rui, C.
Xin-Wei, D.
Lan, X.
Jun-Xia, J.
Qiang-Min, X.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2009, 103 (05) : A131 - A131
[37] MONOCLONAL-ANTIBODY TO THE MURINE TYPE-3 COMPLEMENT RECEPTOR INHIBITS ADHESION OF MYELOMONOCYTIC CELLS-INVITRO AND INFLAMMATORY CELL RECRUITMENT INVIVO
ROSEN, H
GORDON, S
JOURNAL OF EXPERIMENTAL MEDICINE, 1987, 166 (06): : 1685 - 1701
[38] STAT3 inhibition prevents lung inflammation, remodeling, and accumulation of Th2 and Th17 cells in a murine asthma model
Gavino, A. C.
Nahmod, K.
Bharadwaj, U.
Makedonas, G.
Tweardy, D. J.
ALLERGY, 2016, 71 (12) : 1684 - 1692
[39] Indirubin induces tolerogenic dendritic cells via aryl hydrocarbon receptor activation and ameliorates allergic asthma in a murine model by expanding Foxp3-expressing regulatory T cells
Chuang, Hsiao-Chi
Chuang, Kai-Jen
Cheng, Po-Ching
Hsieh, Chia-Ling
Fan, Yen-Yi
Lee, Yueh-Lun
PHYTOMEDICINE, 2024, 135
[40] NK cells mediate Flt3 ligand-induced protection of dendritic cell precursors in vivo from the inhibition by prostate carcinoma in the murine bone marrow metastasis model
Tourkova, IL
Yamabe, F
Chatta, J
Shurin, GV
Shurin, MR
JOURNAL OF IMMUNOTHERAPY, 2003, 26 (06): : 468 - 472

← 1 2 3 4 5 →